Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update | Journal of Clinical Oncology
Breast cancer - The Lancet
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
ASCO 2022 | HER2 Expression Low is Breast Cancer | Cerba Research
Pathologist's Corner – Dr. Hon on Breast Cancer Tissue Handling and Updates for Her-2 Testing
Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast
Protocol for the Examination of Biopsy Specimens From Patients With Invasive Carcinoma of the Breast
Frontiers | Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications
Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases | SpringerLink
CAP Cancer Protocol Bresast Invasive
Association between low estrogen receptor positive breast cancer and staining performance | npj Breast Cancer
Breast Biomarker Reporting Template
Cells | Free Full-Text | MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines | HTML
Pathologist's Corner – Dr. Hon on Breast Cancer Tissue Handling and Updates for Her-2 Testing
Protocol for the Examination of Resection Specimens from Patients with Ductal Carcinoma In Situ (DCIS) of the Breast
Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH - ScienceDirect
Breast Cancer and Hormone Receptor Positive Status - Moose and Doc
Q&A column - Page 2 of 3 - CAP TODAY
Pathologist's Corner – Dr. Hon on Breast Cancer Tissue Handling and Updates for Her-2 Testing
Breast cancer biomarkers, and a new clinical category for HER2 expression | Medical Laboratory Observer
Adjuvant Abemaciclib for HR+/HER2- EBC - Adj Abemaciclib HR+/HER2- EBC - Text Modules - NeoAdjuvant EBC - Oncology - Clinical Care Options
Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy
Protocol for the Examination of Resection Specimens From Patients With Invasive Carcinoma of the Breast
Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer | Modern Pathology
